APLP2 and familial pancreatic carcinoma: Downregulation of APLP2 and/or APP in the pancreatic cancer S2-013 cell line, which displays representatively low expression of APP C-terminal fragments, decreased cell proliferation, suggesting a role for both family members in the growth of pancreatic cancer cell lines.